Moderna (MRNA) closed at $59.49 in the latest trading session, marking a -3.77% move from the prior day. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow experienced a drop of 0.

The pullback appears driven by a mix of profit-taking and cautious Wall Street comments after a whopping 48% rally in June ...

The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.

The answer would seem to put her in direct conflict with Health Secretary RFK Jr.

The two New Jersey suits assert eight patents against Pfizer and 10 against Moderna, extending existing mRNA litigation ...

Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during the Covid-19 pandemic and they helpe ...

CAMBRIDGE, MA / ACCESS Newswire / July 16, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first ...

MASSACHUSETTS - Advisers to the US Food and Drug Administration on June 18 backed approval of Moderna’s flu vaccine for adults aged 50 and older, saying its benefits outweigh the risks, boosting the ...

A Food and Drug Administration advisory panel on Thursday recommended the approval of Moderna’s mRNA-based flu shot for older adults.

Online content falsely claiming vaccines can be distributed through the food supply has circulated for years and a new series of posts repeated claims that mRNA vaccines are being given to shrimp to ...